A federal judge in Louisiana has scheduled an initial court hearing for a batch of lawsuits that claim Takeda Pharmaceuticals’ top-selling diabetes drug, Actos, carries an increased risk of bladder cancer. Takeda’s Japanese parent company, Takeda Pharmaceuticals Co. Ltd., halted sales of Actos in Germany and France last year.
Judge sets 1st hearing for diabetes drug lawsuits
Published February 20, 2012 News Leave a CommentTags: Actos and bladder cancer, Actos bladder cancer, Actos bladder cancer lawsuit, Actos lawsuit, actos recall, actos warning, FDA, Food and Drug Administration, Takeda Pharmaceuticals
0 Responses to “Judge sets 1st hearing for diabetes drug lawsuits”